More support to antiangiogenic therapy as effective in preventing the development of endometriosis has been provided by CAM model studies, in which anti-human VEGF factors administered to the CAM significantly decreased the vascular density of the CAM and prevented endometriosis-like lesion formation after the transplantation of human endometrium [199]. Here, VEGFA is linked to endometriosis.